BENDHEIM JACK (President and CEO) sold 28.8% of their position (21.12K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.17M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
−6.52K
Price / share
$52.88
Trade value
$344.92K
% of position
Class A Common Stock
Shares
−517.00
Price / share
$53.59
Trade value
$27.71K
% of position
Class A Common Stock
Shares
−1.57K
Price / share
$55.28
Trade value
$86.90K
% of position
Class A Common Stock
Shares
−4.92K
Price / share
$56.00
Trade value
$275.32K
% of position
Class A Common Stock
Shares
−552.00
Price / share
$56.86
Trade value
$31.39K
% of position
Class A Common Stock
Shares
−6.76K
Price / share
$56.79
Trade value
$383.87K
% of position
Class A Common Stock
Shares
−280.00
Price / share
$57.17
Trade value
$16.01K
% of position
Net shares
−21.12K
Net value
-$1.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 3/24/2026 | S · Sale | −6.52K | $52.88 | $344.92K | 8.9% | 73.32K | 66.80K |
| Class A Common Stock Indirect | 3/24/2026 | S · Sale | −517.00 | $53.59 | $27.71K | 0.8% | 66.80K | 66.28K |
| Class A Common Stock Indirect | 3/25/2026 | S · Sale | −1.57K | $55.28 | $86.90K | 2.4% | 66.28K | 64.71K |
| Class A Common Stock Indirect | 3/25/2026 | S · Sale | −4.92K | $56.00 | $275.32K | 7.6% | 64.71K | 59.79K |
| Class A Common Stock Indirect | 3/25/2026 | S · Sale | −552.00 | $56.86 | $31.39K | 0.9% | 59.79K | 59.24K |
| Class A Common Stock Indirect | 3/26/2026 | S · Sale | −6.76K | $56.79 | $383.87K | 11.4% | 59.24K | 52.48K |
| Class A Common Stock Indirect | 3/26/2026 | S · Sale | −280.00 | $57.17 | $16.01K | 0.5% | 52.48K | 52.20K |
| Total | −21.12K | -$1.17M | ||||||
Class A Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |